Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Raymond James analyst John Ransom downgraded the rating for HCA Healthcare, Inc. HCA from Outperform to Market Perform. HCA Healthcare shares closed at $332.24 on Thursday. See how other analysts view this stock.
- JMP Securities analyst Matthew Carletti downgraded the rating for Root, Inc. ROOT from Market Outperform to Market Perform. Root shares closed at $109.40 on Thursday. See how other analysts view this stock.
- Needham analyst Mike Matson downgraded TransMedics Group, Inc TMDX from Buy to Hold and maintained the price target of $109. TransMedics shares closed at $79.34 on Thursday. See how other analysts view this stock.
- Keybanc analyst Steve Barger downgraded the rating for The Timken Company TKR from Overweight to Sector Weight. Timken shares closed at $75.22 on Thursday. See how other analysts view this stock.
- B. Riley Securities analyst Alex Rygiel downgraded Atkore Inc. ATKR from Buy to Neutral and lowered the price target from $135 to $84. Atkore shares closed at $85.14 on Thursday. See how other analysts view this stock.
Considering buying HCA stock? Here’s what analysts think:
ATKRAtkore Inc
$57.741.35%
Edge Rankings
Momentum
9.92
Growth
18.82
Quality
91.96
Value
88.41
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|